As regulatory changes globally lead to increased use of exchange traded derivative products, Deutsche Bank is re-focusing its derivatives business with the creation of a new unit specialising in the central clearing of OTC products.

The new business will be headed by Drew Bradford and will be closely aligned with the bank’s prime brokerage business. It already has connections to 61 derivatives exchanges globally.

The move to central clearing for OTC derivatives should result in hedge funds needing increasingly sophisticated global execution, clearing and margin facilities. Deutsche Bank’s launch of the world’s first multi-asset clearing platform, dbClear, earlier this year, demonstrated that the bank was taking its OTC ambitions seriously.

In Asia, listed derivatives sales will be headed by Jason Scott, who joins the bank from Credit Suisse. Working with him will be Anil Desai, who will be a director in listed derivatives sales and was previously head of futures and options trading for J.P. Morgan in India.

In London, Cameron Mouat has been appointed as part of the business development team. He was previously an algorithmic product specialist at Credit Suisse. He will be joined by Paul Daines, who will focus on European execution client solutions, and Yue Meng, who will concentrate on European clearing client solutions, both from Nomura.

In Chicago, Deutsche Bank will re-establish its presence with a team of two, led by Macario Lullo, who joins the bank from Infinium Capital.